Comprehensive and Evaluation of Health-related Life Quality Assessment Through Diverse Cancers
Shirin Jalili,
Ramin Ghasemi Shayan
Issue:
Volume 7, Issue 5, October 2021
Pages:
236-244
Received:
3 September 2021
Accepted:
9 October 2021
Published:
19 October 2021
Abstract: Health assessment data assistances well-being and patient care teams' progress care draw up a plan of and assistance comprehend the requirements of the patient people. Comprehensive and exact data about the Quality of Life of cancer patients play a significant part in the development and organization of cancer patients. Quality of Life has been used to mean variability of various things, such as health position, physical functioning, signs, psychosocial modification, well-being, life pleasure, and gladness. Chronic diseases such as cancer are among the disorders that severely affect people's health and consequently their Quality of Life. Cancer patients experience a range of symptoms, including pain and various physical and mental conditions that negatively affect their Quality of Life. In this article, we examined cancer and the impact that this disease can have on the Quality of Life of cancer patients. The cancers examined in this article include head and neck, prostate, breast, lung, and skin cancers. We also discussed health assessment and the importance and purpose of studying patients' Quality of Life, especially cancer patients; the various signs and symptoms of the disease that affect the Quality of Life of patients were reviewed. The results showed that multiple factors under the quality-of-life assessment could affect the Quality of Life by concentrating on physical, emotional, cognitive, and social.
Abstract: Health assessment data assistances well-being and patient care teams' progress care draw up a plan of and assistance comprehend the requirements of the patient people. Comprehensive and exact data about the Quality of Life of cancer patients play a significant part in the development and organization of cancer patients. Quality of Life has been use...
Show More
Heart Disease Associated with COVID-19 in Children
Emilia Alonso Zurmendi,
Federica Badía De Ferrari,
Maren Karina Machado Echeverría,
Mariangel Ospitaleche,
María Catalina Pirez García
Issue:
Volume 7, Issue 5, October 2021
Pages:
245-249
Received:
30 September 2021
Accepted:
21 October 2021
Published:
30 October 2021
Abstract: Introduction: Heart disease in children associated with COVID-19 is described during acute infection or in the context of the Multisystem inflammatory syndrome in children (MIS-C), and in patients with and without previous heart disease. It has different manifestations: asymptomatic, with alterations in complementary tests (elevated troponins, arrhythmias, imaging changes), up to severe forms: myocardial infarction, heart failure, cardiogenic shock, sudden death. We report a schoolgirl who had severe COVID-19, with cardiac, digestive, and respiratory manifestations. Clinical case: 10-year-old girl, carrier of disabling chronic disease. In the course of severe COVID-19, she added shock and respiratory failure, elevated inflammatory markers, increased troponins, and dilated cardiac cavities, with functional compromise of the left ventricle. She received non-invasive ventilatory assistance, antibiotics, and systemic corticosteroids. Cardiac manifestations reversed, with a decrease in inflammatory parameters. Discussion: The heart is frequently affected in COVID-19. Cardiac injury may be due to: viral replication, systemic inflammatory response, respiratory failure, or myocardial stress. The severity will depend on the extent of the damage and the inflammatory response. Cardiac involvement is more common in those who meet MIS-C criteria. Most recover cardiac function. The case report contributes to the knowledge of SARS-CoV-2 infection, and the severe forms of presentation with cardiac involvement in children highlight the need to advance in primary prevention by vaccines in the pediatric population.
Abstract: Introduction: Heart disease in children associated with COVID-19 is described during acute infection or in the context of the Multisystem inflammatory syndrome in children (MIS-C), and in patients with and without previous heart disease. It has different manifestations: asymptomatic, with alterations in complementary tests (elevated troponins, arrh...
Show More
